Literature DB >> 24359984

Kidney involvement in leukemia and lymphoma.

Randy L Luciano1, Ursula C Brewster2.   

Abstract

Leukemia and lymphoma are hematologic malignancies that can affect any age group. Disease can be aggressive or indolent, often with multiorgan system involvement. Kidney involvement in leukemia and lymphoma can be quite extensive. Acute kidney injury (AKI) is quite prevalent in these patients, with prerenal and acute tubular necrosis being the most common etiologies. However other prerenal, intrinsic, and obstructive etiologies are possible. AKI can be a direct effect of the malignancy, a complication of the malignancy, or the consequence or side effect of chemotherapy. Nephrotic syndrome and glomerulonephritis, often presenting without overt kidney failure, have also been seen in all forms of leukemia and lymphoma. Lastly, the direct effects of the malignancy and complications from the tumor often result in numerous electrolyte disturbances and acid-base disorders, with life-threatening consequences if left untreated.
Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Glomerulonephritis; Leukemia; Lymphoma; Nephrotic syndrome

Mesh:

Year:  2014        PMID: 24359984     DOI: 10.1053/j.ackd.2013.07.004

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  22 in total

1.  Lymphadenopathy, splenomegaly, intermittent neutropenia, and acute kidney injury: Answers.

Authors:  Katie Sullivan; Rose Chami; Rachel Pearl
Journal:  Pediatr Nephrol       Date:  2019-08-29       Impact factor: 3.714

Review 2.  Kidney diseases associated with haematological cancers.

Authors:  Anirban Ganguli; Deirdre Sawinski; Jeffrey S Berns
Journal:  Nat Rev Nephrol       Date:  2015-06-02       Impact factor: 28.314

3.  A rare cause of acute kidney injury with chronic myelomonocytic leukemia.

Authors:  Marina Asano; Hanako Hase; Yuki Naruse; Kyogo Kawada; Iori Kojima; Joel Branch; Hiroshi Kitamura; Hideaki Shimizu
Journal:  CEN Case Rep       Date:  2021-01-06

Review 4.  Myeloid disorders after autoimmune disease.

Authors:  Prajwal C Boddu; Amer M Zeidan
Journal:  Best Pract Res Clin Haematol       Date:  2019-02-07       Impact factor: 3.020

5.  Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study.

Authors:  Abhijat Kitchlu; Eric McArthur; Eitan Amir; Christopher M Booth; Rinku Sutradhar; Habeeb Majeed; Danielle M Nash; Samuel A Silver; Amit X Garg; Christopher T Chan; S Joseph Kim; Ron Wald
Journal:  J Natl Cancer Inst       Date:  2019-07-01       Impact factor: 13.506

6.  Proteomics-inspired precision medicine for treating and understanding multiple myeloma.

Authors:  Matthew Ho; Giada Bianchi; Kenneth C Anderson
Journal:  Expert Rev Precis Med Drug Dev       Date:  2020-02-24

7.  Acute kidney injury and childhood acute myeloid leukemia.

Authors:  Chompoonut Limratchapong; Praewa Sophark; Prayong Vachvanichsanong; Edward B McNeil; Thirachit Chotsampancharoen
Journal:  Pediatr Nephrol       Date:  2022-03-07       Impact factor: 3.651

8.  Antineutrophil cytoplasmic antibody-positive pauci-immune glomerulonephritis associated with mantle cell lymphoma.

Authors:  Kana N Miyata; Nazia A Siddiqi; Lawrence P Kiss; Nikolas B Harbord; James F Winchester
Journal:  Clin Nephrol Case Stud       Date:  2017-02-03

9.  Acute Lymphoblastic Leukemia Presenting as Fanconi Syndrome.

Authors:  Tatsunori Yoshida; Hiroshi Tsujimoto; Takayuki Ichikawa; Shinji Kounami; Hiroyuki Suzuki
Journal:  Case Rep Oncol       Date:  2018-02-01

10.  The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG.

Authors:  Haobin Ye; Mohammad Minhajuddin; Anna Krug; Shanshan Pei; Chih-Hsing Chou; Rachel Culp-Hill; Jessica Ponder; Erik De Bloois; Björn Schniedewind; Maria L Amaya; Anagha Inguva; Brett M Stevens; Daniel A Pollyea; Uwe Christians; H Leighton Grimes; Angelo D'Alessandro; Craig T Jordan
Journal:  Cancer Discov       Date:  2020-10-07       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.